Connect with us

World News

Oman approves Covaxin shots for travel without quarantine

Published

on


“Pre-arrival RT-PCR test will be applicable for such passengers,” read the press release (File)

Muscat:

The government of the Sultanate of Oman on Wednesday added India-made Covaxin to the approved list of COVID-19 vaccines for travel to the country without quarantine.

The Indian Embassy in Muscat tweeted, “Covaxin has now been added to the approved list of COVID-19 vaccines for travel to Oman without quarantine. This will facilitate COVAXIN vaccination for travelers to India.”

“All travelers from India who have received two doses of Covaxin at least 14 days prior to the estimated arrival date will now be able to travel to Oman without the need for quarantine. All other COVID-19 related requirements/conditions, such as from arrival RT-PCR test will be applicable for such passengers first,” read the Indian Embassy’s press release.

This notification will make travel to Oman much easier for Indian citizens who have taken Covaxin. Passengers who have taken AstraZeneca/Covishield are already allowed to travel to Oman without quarantine.

Covaxin, India’s first indigenous COVID-19 vaccine, has been developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research.

Meanwhile, the World Health Organization (WHO) has stated that the Technical Advisory Group (TAG) for the Emergency Use List has decided that additional clarification is needed from the manufacturer to conduct a final EUL risk-benefit assessment for global use of the vaccine. Is.

The UN health body said the TAG is expected to reconvene for a final risk-benefit assessment on November 3.

Bharat Biotech is submitting data to WHO on an ongoing basis and has submitted additional information on 27 September at the request of the UN health body.

Earlier this month, WHO Chief Scientist Dr Soumya Swaminathan said the UN health body’s technical advisory group would meet on October 26 to consider the Emergency Use List (EUL) for Covaxin. Last week, the WHO said there is a vaccine recommended by it for emergency use. should be evaluated thoroughly.

(Except for the title, this story has not been edited by NDTV staff and is published from a syndicated feed.)

.

Copyright Indian Lekhak Limited 2021. All Rights Reserved